EUVIMEDEUVIMED entdecken
Open Access

TBX21 attenuates colorectal cancer progression via an ARHGAP29/RSK/GSK3β dependent manner

Xinyu Jiang, Wenfei Du, Chenglong Yang, Shuying Wang, Yifei Li, Xinzhuang Shen, Xiaowen Yang, Jie Yao, Renle Du, Xiaoyuan Zhang, Yongming Huang, Wenzhi Shen

Cellular Oncology · 2023-10 · 46 (5) · 1269-1283

DOI: 10.1007/s13402-023-00809-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 17.04.2023. Verfasst von Xinyu Jiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Precision Oncology in Universities of Shandong, Institute of Precision Medicine, Jining Medical University, Jining, 272067, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsHumansApoptosisBase SequenceCell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticGlycogen Synthase Kinase 3 betaGTPase-Activating ProteinsSignal TransductionRibosomal Protein S6 Kinases, 90-kDaT-bet Transcription Factor

Stichwörter der Autor:innen

ARHGAP29ApoptosisColorectal cancerGSK3βProliferationRSKTBX21

Substanzen

ARHGAP29 protein, humanGlycogen Synthase Kinase 3 betaGTPase-Activating ProteinsT-bet Transcription FactorRibosomal Protein S6 Kinases, 90-kDa

Autor:innen und Institutionen

  • Key Laboratory of Precision Oncology in Universities of Shandong, Institute of Precision Medicine, Jining Medical University, Jining, 272067, China.
  • The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, 563000, China.
  • Surgery Teaching and Research Section, Clinical Medical School, Jining Medical University, Jining, 272067, China.
  • Department of Oncology, Jining Hospital of Traditional Chinese Medicine, Jining, 272000, China.
  • Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450052, China.
  • Key Laboratory of Precision Oncology in Universities of Shandong, Institute of Precision Medicine, Jining Medical University, Jining, 272067, China. xiaoyuan0321smile@163.com.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Jiang, X., Du, W., Yang, C., Wang, S., Li, Y., Shen, X., Yang, X., Yao, J., Du, R., Zhang, X., Huang, Y., & Shen, W. (2023). TBX21 attenuates colorectal cancer progression via an ARHGAP29/RSK/GSK3β dependent manner. Cellular Oncology, 46(5), 1269-1283. https://doi.org/10.1007/s13402-023-00809-6

Vancouver

Jiang X, Du W, Yang C, Wang S, Li Y, Shen X, et al. TBX21 attenuates colorectal cancer progression via an ARHGAP29/RSK/GSK3β dependent manner. Cellular Oncology. 2023;46(5):1269-1283. doi:10.1007/s13402-023-00809-6

BibTeX
@article{Jiang2023,
  author = {Jiang, Xinyu and Du, Wenfei and Yang, Chenglong and Wang, Shuying and Li, Yifei and Shen, Xinzhuang and Yang, Xiaowen and Yao, Jie and Du, Renle and Zhang, Xiaoyuan and Huang, Yongming and Shen, Wenzhi},
  title = {TBX21 attenuates colorectal cancer progression via an ARHGAP29/RSK/GSK3β dependent manner},
  journal = {Cellular Oncology},
  year = {2023},
  volume = {46},
  number = {5},
  pages = {1269--1283},
  doi = {10.1007/s13402-023-00809-6}
}
Kostenlos starten →